Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 4/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.47 |
| ▸ | FNTA | P49354 | 3/20 | 0.45 |
| ▸ | FNTB | P49356 | 3/20 | 0.45 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.45 |
| ▸ | GNPAT | O15228 | 1/20 | 0.45 |
| ▸ | TFPI | P10646 | 1/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | NPY2R | P49146 | 1/20 | 0.44 |
| ▸ | NPY4R | P50391 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29591949 | 0.95 | OPRM1 (0.47) | OPRD1OPRM1OPRK1TFPINPY1R | |
| SCHEMBL29575686 | 0.93 | OPRD1 (0.49) | OPRD1OPRM1OPRK1FNTAFNTB | |
| SCHEMBL30626300 | 0.93 | OPRD1 (0.53) | OPRD1OPRM1OPRK1GNPATNPY1R | |
| SCHEMBL29630731 | 0.91 | OPRD1 (0.51) | OPRD1OPRM1OPRK1FNTAFNTB | |
| SCHEMBL29569045 | 0.91 | OPRM1 (0.47) | OPRD1OPRM1OPRK1NPY1RNPY2R | |
| SCHEMBL29630522 | 0.91 | OPRD1 (0.49) | OPRD1OPRM1OPRK1NPY1RNPY2R | |
| SCHEMBL29568713 | 0.90 | ERAP2 (0.51) | OPRD1OPRM1OPRK1NPY1RNPY2R | |
| SCHEMBL29569091 | 0.90 | ERAP2 (0.51) | OPRD1OPRM1OPRK1NPY1RNPY2R | |
| SCHEMBL30692724 | 0.90 | OPRD1 (0.53) | OPRD1OPRM1OPRK1GNPATNPY1R | |
| SCHEMBL30903456 | 0.89 | FOLH1 (0.49) | OPRD1OPRM1OPRK1TFPINPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |